MedTrace Logo

SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries

NCT04971772 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2026-03-19

No results posted yet for this study

Summary

The aim of this study is to demonstrate the superiority in safety and efficacy of the Legflow DCB vs standard uncoated POBA in a randomized controlled (RCT) for treatment of patients with symptomatic peripheral artery disease (PAD) due to stenosis, restenosis or occlusion of the femoral and/or popliteal arteries.

Conditions

  • Peripheral Arterial Disease
  • Superficial Femoral Artery Stenosis
  • Angiopathy, Peripheral

Sponsors & Collaborators

  • FCRE (Foundation for Cardiovascular Research and Education)

    collaborator OTHER

  • Cardionovum GmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-08
Primary Completion
2026-12-31
Completion
2028-01-31

Countries

  • Brazil
  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04971772 on ClinicalTrials.gov